J. Daniel Kelly

Mar 6, 2024 | nature.com | Gregg Gonsalves |J. Daniel Kelly |Robert Wachter

AbstractThere is a public health need to understand how different frequencies of COVID-19 booster vaccines may mitigate the risk of severe COVID-19, while accounting for waning of protection and differential risk by age and immune status.

Jul 19, 2023 | nature.com | Danillo G. Augusto |Lawton D. Murdolo |Noah D. Peyser |Victoria W. Murray |Cassandra Yun |Colin T. Maguire | +10 more

AbstractStudies have demonstrated that at least 20% of individuals infected with SARS-CoV-2 remain asymptomatic1,2,3,4. Although most global efforts have focused on severe illness in COVID-19, examining asymptomatic infection provides a unique opportunity to consider early immunological features that promote rapid viral clearance.